CD56 marks an effector T cell subset in the human intestine

被引:26
|
作者
Cohavy, Offer [1 ]
Targan, Stephan R. [1 ]
机构
[1] Cedars Sinai Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 09期
关键词
D O I
10.4049/jimmunol.178.9.5524
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells are key mediators of intestinal immunity, and specific T cell subsets can have differing immunoregulatory roles in animal models of mucosal inflammation. In this study, we describe human CD56(+) T cells as a morphologically distinct population expressing a mature, nonproliferative phenotype that is frequent in the gut. Enhanced potential for IFN-gamma and TNF synthesis suggested a proinflammatory function, and we directly demonstrate effector function mediated by direct T-T interaction with responder cells in vitro. CD56(+) Ir cells from peripheral blood responded to the gut-related CD2 signal, and were necessary for effective CD2-mediated proliferation of peripheral blood CD56(-) T cells. Our findings associate CD56(+) T cells with the intestinal immune compartment and suggest a putative effector function in human mucosal immunity.
引用
收藏
页码:5524 / 5532
页数:9
相关论文
共 50 条
  • [1] CD56 marks human dendritic cell subsets with cytotoxic potential
    Roothans, Dessie
    Smits, Evelien
    Lion, Eva
    Tel, Jurjen
    Anguille, Sebastien
    ONCOIMMUNOLOGY, 2013, 2 (02):
  • [2] RAPID METHOD FOR PURIFICATION OF CD56(+) NATURAL-KILLER-CELLS WITH PREFERENTIAL ENRICHMENT OF THE CD56(BRIGHT+) SUBSET
    HANDGRETINGER, R
    WELTE, B
    DOPFER, R
    NIETHAMMER, D
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1994, 8 (06) : 443 - 446
  • [3] Cutting edge:: Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
    Pittet, MJ
    Speiser, DE
    Valmori, D
    Cerottini, JC
    Romero, P
    JOURNAL OF IMMUNOLOGY, 2000, 164 (03): : 1148 - 1152
  • [4] CD27 Deficiency Causes Human NK Cell Deficiency with Specific Loss of the CD56(bright) Subset: A Single Case Report
    Chaimowitz, Natalia
    Nicholas, Sarah
    Noroski, Leonora
    Forbes, Lisa R.
    Nandiwada, Sara
    Rider, Nicholas
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S36 - S36
  • [5] CD56 participation in immune effector cell activation and tumor cell eradication: A role for interleukin-15
    Van Acker, Heleen H.
    Versteven, Maarten
    De Reu, Hans
    Ponsaerts, Peter
    Berneman, Zwi N.
    Van Tendeloo, Viggo F.
    Smits, Evelien L.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [6] CD56 is a legitimate immune receptor regulating T cell and NK cell effector function, and its expression level predicts successful aging
    de Vallejo, Abbe
    Griffin, Patricia
    Montag, David
    Nussbaum, Ryan
    Gunawardema, Naomi
    Studenski, Stephanie
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [7] Differential phenotypic properties of human peripheral blood CD56(dim+) and CD56(bright+) natural killer cell subpopulations
    Sedlmayr, P
    Schallhammer, L
    Hammer, A
    WildersTruschnig, M
    Wintersteiger, R
    Dohr, G
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 110 (04) : 308 - 313
  • [8] CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia
    Sylvia, Mary Theresa
    Jacob, Sajini Elizabeth
    Basu, Debdatta
    Amalnath, Deepak
    Dutta, Tarun Kumar
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 : S121 - S124
  • [9] CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia
    Mary Theresa Sylvia
    Sajini Elizabeth Jacob
    Debdatta Basu
    Deepak Amalnath
    Tarun Kumar Dutta
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 121 - 124
  • [10] DIFFERENTIAL-DIAGNOSIS OF CD3(+), CD56(+) T-CELL LEUKEMIAS
    KINGMA, DW
    RAFFELD, M
    JAFFE, ES
    BLOOD, 1995, 85 (06) : 1675 - 1676